These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 10877212
21. [Dynamics of the lipoprotein distribution in early hypercholesterolemia characterizes the activation of cholesterol transport]. Bozhko GKh, Kulabukhov VM, Voloshin PV. Biokhimiia; 1991 Oct; 56(10):1886-93. PubMed ID: 1777526 [Abstract] [Full Text] [Related]
22. Blood and plasma viscosity after acipimox treatment in hypertriglyceridemic patients. Montefusco S, Iannaci G, Gnasso A, Cortese C, Lamenza F, Postiglione A. Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):492-4. PubMed ID: 3235215 [Abstract] [Full Text] [Related]
23. Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study. Engström G, Hedblad B, Janzon L, Lindgärde F. Ann Epidemiol; 2007 Jan; 17(1):57-63. PubMed ID: 17178329 [Abstract] [Full Text] [Related]
24. One year experience with a low density lipoprotein apheresis system. Durst R, Rund D, Schurr D, Eliav O, Ben-Yehuda D, Shpizen S, Ben-Avi L, Schaap T, Pelz I, Leitersdorf E. Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228 [Abstract] [Full Text] [Related]
25. Changes in plasma lipoproteins during lipolysis in vivo in the hypertriglyceridemic state. Karakas SE, Khilnani S, Divens C, Almario R, Jen KL. Am J Clin Nutr; 1994 Feb; 59(2):378-83. PubMed ID: 8310988 [Abstract] [Full Text] [Related]
26. [Effects of hypertriglyceridemia on platelet activities in endogenous hypertriglyceridemic patients]. Shen T, Liu BW, Liu Y, Bai H, Zhang ZH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):15-7. PubMed ID: 14981803 [Abstract] [Full Text] [Related]
27. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK. Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [Abstract] [Full Text] [Related]
28. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia. Karalis DG, Ishisaka DY, Luo D, Ntanios F, Wun CC. Am J Cardiol; 2007 Aug 01; 100(3):445-9. PubMed ID: 17659926 [Abstract] [Full Text] [Related]
29. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin. Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA. Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066 [Abstract] [Full Text] [Related]
30. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation. Siirtola A, Antikainen M, Ala-Houhala M, Solakivi T, Jokela H, Lehtimäki T, Holmberg C, Salo MK. J Heart Lung Transplant; 2004 Apr 10; 23(4):418-26. PubMed ID: 15063401 [Abstract] [Full Text] [Related]
31. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness]. Suckfüll M, Thiery J, Wimmer C, Mees K, Schorn K. Laryngorhinootologie; 1997 Aug 10; 76(8):453-7. PubMed ID: 9376027 [Abstract] [Full Text] [Related]
32. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW. Curr Med Res Opin; 2001 Aug 10; 17(1):60-73. PubMed ID: 11464448 [Abstract] [Full Text] [Related]
33. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness]. Walch C, Anderhuber W, Walzl M. Laryngorhinootologie; 1996 Nov 10; 75(11):641-5. PubMed ID: 9063830 [Abstract] [Full Text] [Related]
34. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH. Clin Biochem; 2005 Sep 10; 38(9):806-12. PubMed ID: 15992790 [Abstract] [Full Text] [Related]
36. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH. Arterioscler Thromb Vasc Biol; 2005 Aug 10; 25(8):1691-6. PubMed ID: 15933247 [Abstract] [Full Text] [Related]
37. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes. Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. J Cardiovasc Pharmacol Ther; 2002 Oct 10; 7(4):219-26. PubMed ID: 12490967 [Abstract] [Full Text] [Related]
38. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases]. Mo JK, Li YX, Lei D, Wu DH. Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar 10; 22(3):278-9. PubMed ID: 12390791 [Abstract] [Full Text] [Related]
39. Impact of pancreas and kidney transplantation on determinants of blood and plasma viscosity. Mellinghoff AC, Reininger AJ, Wurzinger LJ, Landgraf R, Hepp KD. Clin Hemorheol Microcirc; 1998 Jul 10; 18(2-3):175-84. PubMed ID: 9699039 [Abstract] [Full Text] [Related]